Operating Expenses Summary of Bavarian Nordic A/S

Bavarian Nordic A/S's latest annual operating expenses in 2023 was 3.02 Billion DKK , up 70.66% from previous year.
Bavarian Nordic A/S's latest quarterly operating expenses in 2024 Q2 was 454.05 Million DKK , up 15.2% from previous quarter.
Bavarian Nordic A/S reported a annual operating expenses of 1.77 Billion DKK in annual operating expenses 2022, up 100.49% from previous year.
Bavarian Nordic A/S reported a annual operating expenses of 883.86 Million DKK in annual operating expenses 2021, up 218.28% from previous year.
Bavarian Nordic A/S reported a quarterly operating expenses of 394.13 Million DKK for 2024 Q1, down -43.84% from previous quarter.
Bavarian Nordic A/S reported a quarterly operating expenses of 756.68 Million DKK for 2023 Q2, up 66.71% from previous quarter.

Annual Operating Expenses Chart of Bavarian Nordic A/S (2023 - 2001)

Historical Annual Operating Expenses of Bavarian Nordic A/S (2023 - 2001)

Year	Operating Expenses	Operating Expenses Growth
2023	3.02 Billion DKK	70.66%
2022	1.77 Billion DKK	100.49%
2021	883.86 Million DKK	218.28%
2020	277.7 Million DKK	-56.35%
2019	636.17 Million DKK	6.03%
2018	599.98 Million DKK	-17.4%
2017	726.34 Million DKK	7.46%
2016	675.94 Million DKK	11.94%
2015	603.86 Million DKK	-14.35%
2014	705.05 Million DKK	1.54%
2013	694.38 Million DKK	29.85%
2012	534.76 Million DKK	24.81%
2011	428.47 Million DKK	24.67%
2010	343.69 Million DKK	24.59%
2009	275.86 Million DKK	17.13%
2008	235.53 Million DKK	-31.13%
2007	342.01 Million DKK	27.49%
2006	268.26 Million DKK	14.09%
2005	235.14 Million DKK	32.96%
2004	176.85 Million DKK	71.02%
2003	103.41 Million DKK	13.3%
2002	91.27 Million DKK	-2.36%
2001	93.48 Million DKK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	454.05 Million DKK	15.2%
2024 Q1	394.13 Million DKK	-43.84%
2023 Q2	756.68 Million DKK	66.71%
2023 FY	3.02 Billion DKK	70.66%
2023 Q3	1.18 Billion DKK	57.01%
2023 Q4	701.82 Million DKK	-40.93%
2023 Q1	453.9 Million DKK	-38.43%
2022 FY	1.77 Billion DKK	100.49%
2022 Q3	491.84 Million DKK	52.27%
2022 Q1	219.97 Million DKK	-3.9%
2022 Q2	323.01 Million DKK	46.84%
2022 Q4	737.21 Million DKK	49.89%
2021 FY	883.86 Million DKK	218.28%
2021 Q1	245.9 Million DKK	-4.0%
2021 Q2	227.33 Million DKK	-7.55%
2021 Q3	181.72 Million DKK	-20.06%
2021 Q4	228.89 Million DKK	25.95%
2020 Q2	207.87 Million DKK	147.76%
2020 Q3	248.95 Million DKK	19.76%
2020 Q4	256.14 Million DKK	2.89%
2020 FY	277.7 Million DKK	-56.35%
2020 Q1	-435.26 Million DKK	-333.8%
2019 Q1	153.58 Million DKK	-6.89%
2019 Q2	148.57 Million DKK	-3.27%
2019 Q3	147.85 Million DKK	-0.48%
2019 FY	636.17 Million DKK	6.03%
2019 Q4	186.16 Million DKK	25.91%
2018 Q2	147.7 Million DKK	-10.51%
2018 FY	599.98 Million DKK	-17.4%
2018 Q1	165.05 Million DKK	-19.2%
2018 Q4	164.94 Million DKK	34.9%
2018 Q3	122.27 Million DKK	-17.22%
2017 FY	726.34 Million DKK	7.46%
2017 Q3	203.52 Million DKK	21.25%
2017 Q2	167.85 Million DKK	11.4%
2017 Q1	150.68 Million DKK	-22.68%
2017 Q4	204.28 Million DKK	0.37%
2016 Q4	194.88 Million DKK	6.86%
2016 Q2	142.28 Million DKK	-9.03%
2016 Q1	156.4 Million DKK	5.13%
2016 FY	675.94 Million DKK	11.94%
2016 Q3	182.36 Million DKK	28.17%
2015 FY	603.86 Million DKK	-14.35%
2015 Q4	148.77 Million DKK	25.99%
2015 Q3	118.08 Million DKK	-23.37%
2015 Q2	154.1 Million DKK	-15.75%
2015 Q1	182.9 Million DKK	-22.58%
2014 Q2	153 Million DKK	10.79%
2014 Q4	236.25 Million DKK	32.95%
2014 Q3	177.7 Million DKK	16.14%
2014 FY	705.05 Million DKK	1.54%
2014 Q1	138.1 Million DKK	-13.79%
2013 Q3	152.2 Million DKK	-41.44%
2013 Q4	160.18 Million DKK	5.24%
2013 FY	694.38 Million DKK	29.85%
2013 Q1	122.1 Million DKK	-34.8%
2013 Q2	259.9 Million DKK	112.86%
2012 FY	534.76 Million DKK	24.81%
2012 Q4	187.26 Million DKK	50.17%
2012 Q3	124.7 Million DKK	7.04%
2012 Q2	116.5 Million DKK	9.6%
2012 Q1	106.3 Million DKK	-20.54%
2011 Q4	133.77 Million DKK	31.03%
2011 FY	428.47 Million DKK	24.67%
2011 Q1	93.5 Million DKK	-15.53%
2011 Q2	99.1 Million DKK	5.99%
2011 Q3	102.1 Million DKK	3.03%
2010 Q2	83.9 Million DKK	24.48%
2010 Q1	67.4 Million DKK	-36.4%
2010 Q4	110.69 Million DKK	35.15%
2010 FY	343.69 Million DKK	24.59%
2010 Q3	81.9 Million DKK	-2.38%
2009 Q2	67.2 Million DKK	3.86%
2009 Q1	64.7 Million DKK	0.0%
2009 FY	275.86 Million DKK	17.13%
2009 Q4	105.96 Million DKK	62.53%
2009 Q3	65.2 Million DKK	-2.98%
2008 FY	235.53 Million DKK	-31.13%
2007 FY	342.01 Million DKK	27.49%
2006 FY	268.26 Million DKK	14.09%
2005 FY	235.14 Million DKK	32.96%
2004 FY	176.85 Million DKK	71.02%
2003 FY	103.41 Million DKK	13.3%
2002 FY	91.27 Million DKK	-2.36%
2001 FY	93.48 Million DKK	0.0%

Peer Operating Expenses Comparison of Bavarian Nordic A/S

Name	Operating Expenses	Operating Expenses Difference
ALK-Abelló A/S	2.36 Billion DKK	-27.659%
Genmab A/S	10.92 Billion DKK	72.323%
Gubra A/S	164.35 Million DKK	-1740.082%
Novo Nordisk A/S	93.92 Billion DKK	96.78%
Orphazyme A/S	27.04 Thousand DKK	-11183768.94%
Pharma Equity Group A/S	24.81 Million DKK	-12088.087%
Zealand Pharma A/S	226.92 Million DKK	-1232.677%

Global Stocks Search

Bavarian Nordic A/S (BAVA.CO)

Operating Expenses Summary of Bavarian Nordic A/S

Annual Operating Expenses Chart of Bavarian Nordic A/S (2023 - 2001)

Historical Annual Operating Expenses of Bavarian Nordic A/S (2023 - 2001)

Peer Operating Expenses Comparison of Bavarian Nordic A/S